ID   PODO_HUMAN              Reviewed;         383 AA.
AC   Q9NP85; B1AM32; B1AM33; Q8N6Q5;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   18-JUN-2025, entry version 187.
DE   RecName: Full=Podocin {ECO:0000303|PubMed:10742096};
GN   Name=NPHS2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1), VARIANTS NPHS2 RP
RP   CYS-92; GLN-138; GLY-160; MET-180 AND TRP-291, AND VARIANT LEU-20.
RC   TISSUE=Kidney;
RX   PubMed=10742096; DOI=10.1038/74166;
RA   Boute N., Gribouval O., Roselli S., Benessy F., Lee H., Fuchshuber A.,
RA   Dahan K., Gubler M.-C., Niaudet P., Antignac C.;
RT   "NPHS2, encoding the glomerular protein podocin, is mutated in autosomal
RT   recessive steroid-resistant nephrotic syndrome.";
RL   Nat. Genet. 24:349-354(2000).
RN   [2]
RP   ERRATUM OF PUBMED:10742096.
RX   PubMed=10802674; DOI=10.1038/75532;
RA   Boute N., Gribouval O., Roselli S., Benessy F., Lee H., Fuchshuber A.,
RA   Dahan K., Gubler M.-C., Niaudet P., Antignac C.;
RL   Nat. Genet. 25:125-125(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Colon, and Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH NPHS1.
RX   PubMed=11562357; DOI=10.1074/jbc.c100452200;
RA   Huber T.B., Kottgen M., Schilling B., Walz G., Benzing T.;
RT   "Interaction with podocin facilitates nephrin signaling.";
RL   J. Biol. Chem. 276:41543-41546(2001).
RN   [7]
RP   ALTERNATIVE SPLICING (ISOFORM 2), SUBCELLULAR LOCATION (ISOFORM 2), AND
RP   GLYCOSYLATION AT ASN-287 (ISOFORM 2).
RC   TISSUE=Kidney;
RX   PubMed=23648087; DOI=10.1186/1471-2369-14-102;
RA   Volker L.A., Schurek E.M., Rinschen M.M., Tax J., Schutte B.A.,
RA   Lamkemeyer T., Ungrue D., Schermer B., Benzing T., Hohne M.;
RT   "Characterization of a short isoform of the kidney protein podocin in human
RT   kidney.";
RL   BMC Nephrol. 14:102-102(2013).
RN   [8]
RP   VARIANT NPHS2 GLN-229, AND INVOLVEMENT IN NPHS2.
RX   PubMed=12464671; DOI=10.1172/jci16242;
RA   Tsukaguchi H., Sudhakar A., Le T.C., Nguyen T., Yao J., Schwimmer J.A.,
RA   Schachter A.D., Poch E., Abreu P.F., Appel G.B., Pereira A.B., Kalluri R.,
RA   Pollak M.R.;
RT   "NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is
RT   a common disease-associated allele.";
RL   J. Clin. Invest. 110:1659-1666(2002).
RN   [9]
RP   VARIANT GLU-34.
RX   PubMed=12687458; DOI=10.1007/s00467-003-1120-6;
RA   Maruyama K., Iijima K., Ikeda M., Kitamura A., Tsukaguchi H., Yoshiya K.,
RA   Hoshii S., Wada N., Uemura O., Satomura K., Honda M., Yoshikawa N.;
RT   "NPHS2 mutations in sporadic steroid-resistant nephrotic syndrome in
RT   Japanese children.";
RL   Pediatr. Nephrol. 18:412-416(2003).
RN   [10]
RP   VARIANTS NPHS2 THR-29; LEU-118; CYS-168; HIS-168; SER-168; VAL-172;
RP   THR-208; 236-LEU--ARG-238 DEL; SER-238 AND GLU-260, AND VARIANTS VAL-61;
RP   GLN-237 AND VAL-242.
RX   PubMed=15253708; DOI=10.1111/j.1523-1755.2004.00776.x;
RA   Weber S., Gribouval O., Esquivel E.L., Moriniere V., Tete M.J.,
RA   Legendre C., Niaudet P., Antignac C.;
RT   "NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant
RT   nephrotic syndrome and low post-transplant recurrence.";
RL   Kidney Int. 66:571-579(2004).
RN   [11]
RP   VARIANTS ALA-44 AND VAL-61.
RX   PubMed=15954915; DOI=10.1111/j.1523-1755.2005.00400.x;
RA   Dusel J.A., Burdon K.P., Hicks P.J., Hawkins G.A., Bowden D.W.,
RA   Freedman B.I.;
RT   "Identification of podocin (NPHS2) gene mutations in African Americans with
RT   nondiabetic end-stage renal disease.";
RL   Kidney Int. 68:256-262(2005).
RN   [12]
RP   VARIANTS NPHS2 GLY-3; THR-18; MET-26; MET-28; GLN-30; LYS-30; LEU-39;
RP   THR-89; THR-115; LEU-122; TRP-124; VAL-192; ALA-211; THR-213; GLY-218;
RP   ASP-228; LEU-229; ASN-267; LEU-268; LEU-276; ALA-301 DEL; GLN-322 AND
RP   GLY-370.
RX   PubMed=17899208; DOI=10.1007/s00467-007-0595-y;
RA   Berdeli A., Mir S., Yavascan O., Serdaroglu E., Bak M., Aksu N., Oner A.,
RA   Anarat A., Donmez O., Yildiz N., Sever L., Tabel Y., Dusunsel R.,
RA   Sonmez F., Cakar N.;
RT   "NPHS2 (podicin) mutations in Turkish children with idiopathic nephrotic
RT   syndrome.";
RL   Pediatr. Nephrol. 22:2031-2040(2007).
RN   [13]
RP   VARIANTS NPHS2 138-ARG--LEU-383 DEL; GLN-138; HIS-168; GLN-229; TRP-291;
RP   VAL-310 AND ARG-328, AND VARIANTS MET-290 AND VAL-297.
RX   PubMed=20798252; DOI=10.2215/cjn.01190210;
RA   Buescher A.K., Kranz B., Buescher R., Hildebrandt F., Dworniczak B.,
RA   Pennekamp P., Kuwertz-Broeking E., Wingen A.M., John U., Kemper M.,
RA   Monnens L., Hoyer P.F., Weber S., Konrad M.;
RT   "Immunosuppression and renal outcome in congenital and pediatric steroid-
RT   resistant nephrotic syndrome.";
RL   Clin. J. Am. Soc. Nephrol. 5:2075-2084(2010).
RN   [14]
RP   VARIANT GLN-229.
RX   PubMed=21722858; DOI=10.1016/j.ajhg.2011.05.026;
RA   Ozaltin F., Ibsirlioglu T., Taskiran E.Z., Baydar D.E., Kaymaz F.,
RA   Buyukcelik M., Kilic B.D., Balat A., Iatropoulos P., Asan E., Akarsu N.A.,
RA   Schaefer F., Yilmaz E., Bakkaloglu A.;
RT   "Disruption of PTPRO causes childhood-onset nephrotic syndrome.";
RL   Am. J. Hum. Genet. 89:139-147(2011).
RN   [15]
RP   VARIANTS NPHS2 PRO-116; ILE-187; ILE-221 AND ALA-281, AND VARIANT GLN-264.
RX   PubMed=20947785; DOI=10.2215/cjn.03770410;
RA   Santin S., Tazon-Vega B., Silva I., Cobo M.A., Gimenez I., Ruiz P.,
RA   Garcia-Maset R., Ballarin J., Torra R., Ars E., Fraga G., Mendizabel S.,
RA   Zamora I., Pena A., Espinosa L., Garcia C., Melgosa M., Navarro M.,
RA   Lopez-Hellin J., Chocron S., Madrid A., Vilalta R., Nieto J.L., Ventura C.,
RA   Gimenez A., Cots J.V., Camacho J.A., Sanchez-Moreno A., de la Cerda F.,
RA   Salido E., Ortiz A., Alexandra S., Caramelo C., Egido J., Bernis C.,
RA   Luque de Pablos A., Morales San Jose M.D., Pintos G., Sala P., Raspall F.,
RA   Vila A., Daza M., Vazquez M., Ecija L., Espinosa M., Poveda R.,
RA   Mirapeix E., Vallejo G., Aparicio C., Rosell J., de Sotto D., Muley R.,
RA   Montenegro J., Gonzalez D., Barajas de Frutos D., Trillo E.,
RA   Gainza de los Rios F.J., Justa M.L., Hidalgo-Barquero E.;
RT   "Clinical value of NPHS2 analysis in early- and adult-onset steroid-
RT   resistant nephrotic syndrome.";
RL   Clin. J. Am. Soc. Nephrol. 6:344-354(2011).
RN   [16]
RP   VARIANT NPHS2 MET-290.
RX   PubMed=22578956;
RA   Reiterova J., Safrankova H., Obeidova L., Stekrova J., Maixnerova D.,
RA   Merta M., Tesar V.;
RT   "Mutational analysis of the NPHS2 gene in Czech patients with idiopathic
RT   nephrotic syndrome.";
RL   Folia Biol. (Praha) 58:64-68(2012).
RN   [17]
RP   VARIANTS NPHS2 ASN-126; GLU-260 AND SER-341.
RX   PubMed=22565185; DOI=10.1016/j.gene.2012.04.063;
RA   Abid A., Khaliq S., Shahid S., Lanewala A., Mubarak M., Hashmi S., Kazi J.,
RA   Masood T., Hafeez F., Naqvi S.A., Rizvi S.A., Mehdi S.Q.;
RT   "A spectrum of novel NPHS1 and NPHS2 gene mutations in pediatric nephrotic
RT   syndrome patients from Pakistan.";
RL   Gene 502:133-137(2012).
RN   [18]
RP   VARIANTS NPHS2 ARG-139 AND PRO-142.
RX   PubMed=23913389; DOI=10.4238/2013.june.24.1;
RA   Carrasco-Miranda J.S., Garcia-Alvarez R., Sotelo-Mundo R.R., Valenzuela O.,
RA   Islas-Osuna M.A., Sotelo-Cruz N.;
RT   "Mutations in NPHS2 (podocin) in Mexican children with nephrotic syndrome
RT   who respond to standard steroid treatment.";
RL   Genet. Mol. Res. 12:2102-2107(2013).
RN   [19]
RP   VARIANTS NPHS2 LEU-118; GLY-160; CYS-168; MET-180 AND SER-238.
RX   PubMed=24072147;
RA   Basiratnia M., Yavarian M., Torabinezhad S., Erjaee A.;
RT   "NPHS2 gene in steroid-resistant nephrotic syndrome: prevalence, clinical
RT   course, and mutational spectrum in South-West Iranian children.";
RL   Iran. J. Kidney Dis. 7:357-362(2013).
RN   [20]
RP   VARIANTS NPHS2 39-GLN--LEU-383 DEL; PRO-138; HIS-168; MET-180; PHE-254 AND
RP   GLU-260, AND VARIANT GLN-237.
RX   PubMed=23595123; DOI=10.1038/jhg.2013.27;
RA   Al-Hamed M.H., Al-Sabban E., Al-Mojalli H., Al-Harbi N., Faqeih E.,
RA   Al Shaya H., Alhasan K., Al-Hissi S., Rajab M., Edwards N., Al-Abbad A.,
RA   Al-Hassoun I., Sayer J.A., Meyer B.F.;
RT   "A molecular genetic analysis of childhood nephrotic syndrome in a cohort
RT   of Saudi Arabian families.";
RL   J. Hum. Genet. 58:480-489(2013).
RN   [21]
RP   VARIANTS NPHS2 GLN-138 AND MET-290.
RX   PubMed=23242530; DOI=10.1007/s00467-012-2379-2;
RA   Kerti A., Csohany R., Szabo A., Arkossy O., Sallay P., Moriniere V.,
RA   Vega-Warner V., Nyiro G., Lakatos O., Szabo T., Lipska B.S., Schaefer F.,
RA   Antignac C., Reusz G., Tulassay T., Tory K.;
RT   "NPHS2 p.V290M mutation in late-onset steroid-resistant nephrotic
RT   syndrome.";
RL   Pediatr. Nephrol. 28:751-757(2013).
RN   [22]
RP   VARIANT NPHS2 GLN-229, AND POSSIBLE ROLE AS DISEASE MODIFIER IN NPHS2.
RX   PubMed=23800802; DOI=10.1007/s00467-013-2542-4;
RA   Kerti A., Csohany R., Wagner L., Javorszky E., Maka E., Tory K.;
RT   "NPHS2 homozygous p.R229Q variant: potential modifier instead of causal
RT   effect in focal segmental glomerulosclerosis.";
RL   Pediatr. Nephrol. 28:2061-2064(2013).
RN   [23]
RP   VARIANTS NPHS2 SER-97; PRO-107; SER-122; VAL-175; TYR-183; LYS-281;
RP   LYS-296; VAL-309; ILE-315 AND GLY-333, AND VARIANTS LEU-20; GLN-237 AND
RP   GLN-264.
RX   PubMed=24227627; DOI=10.1002/humu.22485;
RA   Bouchireb K., Boyer O., Gribouval O., Nevo F., Huynh-Cong E., Moriniere V.,
RA   Campait R., Ars E., Brackman D., Dantal J., Eckart P., Gigante M.,
RA   Lipska B.S., Liutkus A., Megarbane A., Mohsin N., Ozaltin F., Saleem M.A.,
RA   Schaefer F., Soulami K., Torra R., Garcelon N., Mollet G., Dahan K.,
RA   Antignac C.;
RT   "NPHS2 mutations in steroid-resistant nephrotic syndrome: a mutation update
RT   and the associated phenotypic spectrum.";
RL   Hum. Mutat. 35:178-186(2014).
RN   [24]
RP   VARIANT NPHS2 GLN-229.
RX   PubMed=24509478; DOI=10.1038/ng.2898;
RA   Tory K., Menyhard D.K., Woerner S., Nevo F., Gribouval O., Kerti A.,
RA   Straner P., Arrondel C., Cong E.H., Tulassay T., Mollet G., Perczel A.,
RA   Antignac C.;
RT   "Mutation-dependent recessive inheritance of NPHS2-associated steroid-
RT   resistant nephrotic syndrome.";
RL   Nat. Genet. 46:299-304(2014).
RN   [25]
RP   VARIANTS NPHS2 GLN-229; GLU-260; VAL-284 AND LYS-310.
RX   PubMed=26420286; DOI=10.1186/s12881-015-0231-9;
RA   Guaragna M.S., Lutaif A.C., Piveta C.S., Souza M.L., de Souza S.R.,
RA   Henriques T.B., Maciel-Guerra A.T., Belangero V.M., Guerra-Junior G.,
RA   De Mello M.P.;
RT   "NPHS2 mutations account for only 15% of nephrotic syndrome cases.";
RL   BMC Med. Genet. 16:88-88(2015).
RN   [26]
RP   VARIANT NPHS2 GLN-229.
RX   PubMed=27004616; DOI=10.1038/ejhg.2016.24;
RA   Lamont R.E., Tan W.H., Innes A.M., Parboosingh J.S., Schneidman-Duhovny D.,
RA   Rajkovic A., Pappas J., Altschwager P., DeWard S., Fulton A., Gray K.J.,
RA   Krall M., Mehta L., Rodan L.H., Saller D.N. Jr., Steele D., Stein D.,
RA   Yatsenko S.A., Bernier F.P., Slavotinek A.M.;
RT   "Expansion of phenotype and genotypic data in CRB2-related syndrome.";
RL   Eur. J. Hum. Genet. 24:1436-1444(2016).
CC   -!- FUNCTION: Plays a role in the regulation of glomerular permeability,
CC       acting probably as a linker between the plasma membrane and the
CC       cytoskeleton.
CC   -!- SUBUNIT: Interacts with nephrin/NPHS1 and KIRREL1. Interacts directly
CC       with CD2AP. Interacts with DDN (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q9NP85; P46940: IQGAP1; NbExp=4; IntAct=EBI-6897706, EBI-297509;
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Cell membrane {ECO:0000305};
CC       Peripheral membrane protein {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Endoplasmic reticulum
CC       {ECO:0000269|PubMed:23648087}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NP85-1; Sequence=Displayed;
CC       Name=2; Synonyms=Pod-short;
CC         IsoId=Q9NP85-2; Sequence=VSP_000499;
CC   -!- TISSUE SPECIFICITY: Almost exclusively expressed in the podocytes of
CC       fetal and mature kidney glomeruli.
CC   -!- PTM: [Isoform 2]: Glycosylated. {ECO:0000269|PubMed:23648087}.
CC   -!- DISEASE: Nephrotic syndrome 2 (NPHS2) [MIM:600995]: A form of nephrotic
CC       syndrome, a renal disease clinically characterized by severe
CC       proteinuria, resulting in complications such as hypoalbuminemia,
CC       hyperlipidemia and edema. Kidney biopsies show non-specific histologic
CC       changes such as focal segmental glomerulosclerosis and diffuse
CC       mesangial proliferation. The disorder is resistant to steroid treatment
CC       and progresses to end-stage renal failure in the first or second
CC       decades. Some patients show later onset of the disorder.
CC       {ECO:0000269|PubMed:10742096, ECO:0000269|PubMed:12464671,
CC       ECO:0000269|PubMed:15253708, ECO:0000269|PubMed:17899208,
CC       ECO:0000269|PubMed:20798252, ECO:0000269|PubMed:20947785,
CC       ECO:0000269|PubMed:22565185, ECO:0000269|PubMed:22578956,
CC       ECO:0000269|PubMed:23242530, ECO:0000269|PubMed:23595123,
CC       ECO:0000269|PubMed:23800802, ECO:0000269|PubMed:23913389,
CC       ECO:0000269|PubMed:24072147, ECO:0000269|PubMed:24227627,
CC       ECO:0000269|PubMed:24509478, ECO:0000269|PubMed:26420286,
CC       ECO:0000269|PubMed:27004616}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the band 7/mec-2 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Nephrosis 2, idiopathic, steroid-resistant (podocin)
CC       (NPHS2); Note=Leiden Open Variation Database (LOVD);
CC       URL="https://databases.lovd.nl/shared/genes/NPHS2";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ279246; CAB83272.1; -; Genomic_DNA.
DR   EMBL; AJ279247; CAB83272.1; JOINED; Genomic_DNA.
DR   EMBL; AJ279248; CAB83272.1; JOINED; Genomic_DNA.
DR   EMBL; AJ279249; CAB83272.1; JOINED; Genomic_DNA.
DR   EMBL; AJ279250; CAB83272.1; JOINED; Genomic_DNA.
DR   EMBL; AJ279251; CAB83272.1; JOINED; Genomic_DNA.
DR   EMBL; AJ279252; CAB83272.1; JOINED; Genomic_DNA.
DR   EMBL; AJ279253; CAB83272.1; JOINED; Genomic_DNA.
DR   EMBL; AJ279254; CAB83216.1; -; mRNA.
DR   EMBL; AL160286; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471067; EAW91049.1; -; Genomic_DNA.
DR   EMBL; CH471067; EAW91050.1; -; Genomic_DNA.
DR   EMBL; BC029141; AAH29141.1; -; mRNA.
DR   CCDS; CCDS1331.1; -. [Q9NP85-1]
DR   CCDS; CCDS72988.1; -. [Q9NP85-2]
DR   RefSeq; NP_001284504.1; NM_001297575.2. [Q9NP85-2]
DR   RefSeq; NP_055440.1; NM_014625.4. [Q9NP85-1]
DR   AlphaFoldDB; Q9NP85; -.
DR   SMR; Q9NP85; -.
DR   BioGRID; 113590; 9.
DR   FunCoup; Q9NP85; 35.
DR   IntAct; Q9NP85; 1.
DR   STRING; 9606.ENSP00000356587; -.
DR   TCDB; 8.A.21.1.2; the stomatin/podocin/band 7/nephrosis,2/spfh (stomatin) family.
DR   GlyCosmos; Q9NP85; 1 site, No reported glycans.
DR   iPTMnet; Q9NP85; -.
DR   PhosphoSitePlus; Q9NP85; -.
DR   BioMuta; NPHS2; -.
DR   DMDM; 12230467; -.
DR   MassIVE; Q9NP85; -.
DR   PaxDb; 9606-ENSP00000356587; -.
DR   PeptideAtlas; Q9NP85; -.
DR   ProteomicsDB; 81929; -. [Q9NP85-1]
DR   ProteomicsDB; 81930; -. [Q9NP85-2]
DR   Antibodypedia; 34420; 135 antibodies from 30 providers.
DR   DNASU; 7827; -.
DR   Ensembl; ENST00000367615.9; ENSP00000356587.4; ENSG00000116218.13. [Q9NP85-1]
DR   Ensembl; ENST00000367616.4; ENSP00000356588.4; ENSG00000116218.13. [Q9NP85-2]
DR   GeneID; 7827; -.
DR   KEGG; hsa:7827; -.
DR   MANE-Select; ENST00000367615.9; ENSP00000356587.4; NM_014625.4; NP_055440.1.
DR   UCSC; uc001gmq.5; human. [Q9NP85-1]
DR   AGR; HGNC:13394; -.
DR   CTD; 7827; -.
DR   DisGeNET; 7827; -.
DR   GeneCards; NPHS2; -.
DR   HGNC; HGNC:13394; NPHS2.
DR   HPA; ENSG00000116218; Tissue enriched (kidney).
DR   MalaCards; NPHS2; -.
DR   MIM; 600995; phenotype.
DR   MIM; 604766; gene.
DR   OpenTargets; ENSG00000116218; -.
DR   Orphanet; 656; Hereditary steroid-resistant nephrotic syndrome.
DR   VEuPathDB; HostDB:ENSG00000116218; -.
DR   eggNOG; KOG2621; Eukaryota.
DR   GeneTree; ENSGT01030000234614; -.
DR   HOGENOM; CLU_024949_3_0_1; -.
DR   InParanoid; Q9NP85; -.
DR   OMA; AWDGFRA; -.
DR   OrthoDB; 2105077at2759; -.
DR   PAN-GO; Q9NP85; 1 GO annotation based on evolutionary models.
DR   PhylomeDB; Q9NP85; -.
DR   PathwayCommons; Q9NP85; -.
DR   Reactome; R-HSA-373753; Nephrin family interactions.
DR   SignaLink; Q9NP85; -.
DR   BioGRID-ORCS; 7827; 11 hits in 1143 CRISPR screens.
DR   ChiTaRS; NPHS2; human.
DR   GeneWiki; NPHS2; -.
DR   GenomeRNAi; 7827; -.
DR   Pharos; Q9NP85; Tbio.
DR   PRO; PR:Q9NP85; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q9NP85; protein.
DR   Bgee; ENSG00000116218; Expressed in renal glomerulus and 34 other cell types or tissues.
DR   GO; GO:0005911; C:cell-cell junction; IDA:UniProtKB.
DR   GO; GO:0009898; C:cytoplasmic side of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0036057; C:slit diaphragm; IEA:Ensembl.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IDA:UniProtKB.
DR   GO; GO:0010467; P:gene expression; IEA:Ensembl.
DR   GO; GO:0003094; P:glomerular filtration; TAS:ProtInc.
DR   GO; GO:0072249; P:metanephric podocyte development; IEP:UniProtKB.
DR   CDD; cd08827; SPFH_podocin; 1.
DR   FunFam; 3.30.479.30:FF:000004; Putative membrane protease family, stomatin; 1.
DR   Gene3D; 6.10.250.2090; -; 1.
DR   Gene3D; 3.30.479.30; Band 7 domain; 1.
DR   InterPro; IPR043202; Band-7_stomatin-like.
DR   InterPro; IPR001107; Band_7.
DR   InterPro; IPR036013; Band_7/SPFH_dom_sf.
DR   InterPro; IPR018080; Band_7/stomatin-like_CS.
DR   InterPro; IPR001972; Stomatin_HflK_fam.
DR   PANTHER; PTHR10264; BAND 7 PROTEIN-RELATED; 1.
DR   PANTHER; PTHR10264:SF127; PODOCIN; 1.
DR   Pfam; PF01145; Band_7; 1.
DR   PRINTS; PR00721; STOMATIN.
DR   SMART; SM00244; PHB; 1.
DR   SUPFAM; SSF117892; Band 7/SPFH domain; 1.
DR   PROSITE; PS01270; BAND_7; 1.
DR   neXtProt; NX_Q9NP85; -.
DR   PharmGKB; PA31710; -.
DR   TreeFam; TF105750; -.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Disease variant;
KW   Endoplasmic reticulum; Glycoprotein; Lipoprotein; Membrane; Palmitate;
KW   Proteomics identification; Reference proteome.
FT   CHAIN           1..383
FT                   /note="Podocin"
FT                   /id="PRO_0000094035"
FT   TOPO_DOM        1..102
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   INTRAMEM        103..123
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        124..383
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          1..76
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          355..383
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..41
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        374..383
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   LIPID           101
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         179..246
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_000499"
FT   VARIANT         3
FT                   /note="R -> G (in NPHS2)"
FT                   /evidence="ECO:0000269|PubMed:17899208"
FT                   /id="VAR_072134"
FT   VARIANT         18
FT                   /note="R -> T (in NPHS2)"
FT                   /evidence="ECO:0000269|PubMed:17899208"
FT                   /id="VAR_072135"
FT   VARIANT         20
FT                   /note="P -> L (in dbSNP:rs74315344)"
FT                   /evidence="ECO:0000269|PubMed:10742096,
FT                   ECO:0000269|PubMed:24227627"
FT                   /id="VAR_010231"
FT   VARIANT         26
FT                   /note="R -> M (in NPHS2)"
FT                   /evidence="ECO:0000269|PubMed:17899208"
FT                   /id="VAR_072136"
FT   VARIANT         28
FT                   /note="K -> M (in NPHS2; dbSNP:rs1340195940)"
FT                   /evidence="ECO:0000269|PubMed:17899208"
FT                   /id="VAR_072137"
FT   VARIANT         29
FT                   /note="A -> T (in NPHS2; dbSNP:rs561887984)"
FT                   /evidence="ECO:0000269|PubMed:15253708"
FT                   /id="VAR_071212"
FT   VARIANT         30
FT                   /note="E -> K (in NPHS2; dbSNP:rs1477180313)"
FT                   /evidence="ECO:0000269|PubMed:17899208"
FT                   /id="VAR_072138"
FT   VARIANT         30
FT                   /note="E -> Q (in NPHS2)"
FT                   /evidence="ECO:0000269|PubMed:17899208"
FT                   /id="VAR_072139"
FT   VARIANT         34
FT                   /note="G -> E (in dbSNP:rs1674742844)"
FT                   /evidence="ECO:0000269|PubMed:12687458"
FT                   /id="VAR_071213"
FT   VARIANT         39..383
FT                   /note="Missing (in NPHS2)"
FT                   /evidence="ECO:0000269|PubMed:23595123"
FT                   /id="VAR_087597"
FT   VARIANT         39
FT                   /note="Q -> L (in NPHS2)"
FT                   /evidence="ECO:0000269|PubMed:17899208"
FT                   /id="VAR_072140"
FT   VARIANT         44
FT                   /note="E -> A"
FT                   /evidence="ECO:0000269|PubMed:15954915"
FT                   /id="VAR_071214"
FT   VARIANT         61
FT                   /note="A -> V (in dbSNP:rs201050491)"
FT                   /evidence="ECO:0000269|PubMed:15253708,
FT                   ECO:0000269|PubMed:15954915"
FT                   /id="VAR_071215"
FT   VARIANT         89
FT                   /note="P -> T (in NPHS2)"
FT                   /evidence="ECO:0000269|PubMed:17899208"
FT                   /id="VAR_072141"
FT   VARIANT         92
FT                   /note="G -> C (in NPHS2; dbSNP:rs74315345)"
FT                   /evidence="ECO:0000269|PubMed:10742096"
FT                   /id="VAR_010232"
FT   VARIANT         97
FT                   /note="G -> S (in NPHS2; uncertain significance;
FT                   dbSNP:rs200913299)"
FT                   /evidence="ECO:0000269|PubMed:24227627"
FT                   /id="VAR_071216"
FT   VARIANT         107
FT                   /note="L -> P (in NPHS2)"
FT                   /evidence="ECO:0000269|PubMed:24227627"
FT                   /id="VAR_071217"
FT   VARIANT         115
FT                   /note="M -> T (in NPHS2)"
FT                   /evidence="ECO:0000269|PubMed:17899208"
FT                   /id="VAR_072142"
FT   VARIANT         116
FT                   /note="T -> P (in NPHS2)"
FT                   /evidence="ECO:0000269|PubMed:20947785"
FT                   /id="VAR_071218"
FT   VARIANT         118
FT                   /note="P -> L (in NPHS2; dbSNP:rs869025495)"
FT                   /evidence="ECO:0000269|PubMed:15253708,
FT                   ECO:0000269|PubMed:24072147"
FT                   /id="VAR_071219"
FT   VARIANT         122
FT                   /note="W -> L (in NPHS2; dbSNP:rs750332447)"
FT                   /evidence="ECO:0000269|PubMed:17899208"
FT                   /id="VAR_072143"
FT   VARIANT         122
FT                   /note="W -> S (in NPHS2; dbSNP:rs750332447)"
FT                   /evidence="ECO:0000269|PubMed:24227627"
FT                   /id="VAR_071220"
FT   VARIANT         124
FT                   /note="C -> W (in NPHS2; dbSNP:rs139290621)"
FT                   /evidence="ECO:0000269|PubMed:17899208"
FT                   /id="VAR_072144"
FT   VARIANT         126
FT                   /note="K -> N (in NPHS2; dbSNP:rs267598208)"
FT                   /evidence="ECO:0000269|PubMed:22565185"
FT                   /id="VAR_072145"
FT   VARIANT         138..383
FT                   /note="Missing (in NPHS2)"
FT                   /evidence="ECO:0000269|PubMed:20798252"
FT                   /id="VAR_079808"
FT   VARIANT         138
FT                   /note="R -> P (in NPHS2)"
FT                   /evidence="ECO:0000269|PubMed:23595123"
FT                   /id="VAR_087598"
FT   VARIANT         138
FT                   /note="R -> Q (in NPHS2; dbSNP:rs74315342)"
FT                   /evidence="ECO:0000269|PubMed:10742096,
FT                   ECO:0000269|PubMed:20798252, ECO:0000269|PubMed:23242530"
FT                   /id="VAR_010233"
FT   VARIANT         139
FT                   /note="L -> R (in NPHS2; dbSNP:rs1345260812)"
FT                   /evidence="ECO:0000269|PubMed:23913389"
FT                   /id="VAR_072146"
FT   VARIANT         142
FT                   /note="L -> P (in NPHS2; dbSNP:rs12240233)"
FT                   /evidence="ECO:0000269|PubMed:23913389"
FT                   /id="VAR_072147"
FT   VARIANT         160
FT                   /note="D -> G (in NPHS2; dbSNP:rs74315346)"
FT                   /evidence="ECO:0000269|PubMed:10742096,
FT                   ECO:0000269|PubMed:24072147"
FT                   /id="VAR_010234"
FT   VARIANT         168
FT                   /note="R -> C (in NPHS2; dbSNP:rs786204583)"
FT                   /evidence="ECO:0000269|PubMed:15253708,
FT                   ECO:0000269|PubMed:24072147"
FT                   /id="VAR_071221"
FT   VARIANT         168
FT                   /note="R -> H (in NPHS2; dbSNP:rs530318579)"
FT                   /evidence="ECO:0000269|PubMed:15253708,
FT                   ECO:0000269|PubMed:20798252, ECO:0000269|PubMed:23595123"
FT                   /id="VAR_071222"
FT   VARIANT         168
FT                   /note="R -> S (in NPHS2)"
FT                   /evidence="ECO:0000269|PubMed:15253708"
FT                   /id="VAR_071223"
FT   VARIANT         172
FT                   /note="L -> V (in NPHS2; uncertain significance)"
FT                   /evidence="ECO:0000269|PubMed:15253708"
FT                   /id="VAR_071224"
FT   VARIANT         175
FT                   /note="P -> V (in NPHS2; requires 2 nucleotide
FT                   substitutions)"
FT                   /evidence="ECO:0000269|PubMed:24227627"
FT                   /id="VAR_071225"
FT   VARIANT         180
FT                   /note="V -> M (in NPHS2; dbSNP:rs74315347)"
FT                   /evidence="ECO:0000269|PubMed:10742096,
FT                   ECO:0000269|PubMed:23595123, ECO:0000269|PubMed:24072147"
FT                   /id="VAR_010235"
FT   VARIANT         183
FT                   /note="D -> Y (in NPHS2; dbSNP:rs2125784628)"
FT                   /evidence="ECO:0000269|PubMed:24227627"
FT                   /id="VAR_071226"
FT   VARIANT         187
FT                   /note="M -> I (in NPHS2; uncertain significance;
FT                   dbSNP:rs1673966819)"
FT                   /evidence="ECO:0000269|PubMed:20947785"
FT                   /id="VAR_071227"
FT   VARIANT         192
FT                   /note="I -> V (in NPHS2)"
FT                   /evidence="ECO:0000269|PubMed:17899208"
FT                   /id="VAR_072148"
FT   VARIANT         208
FT                   /note="A -> T (in NPHS2; dbSNP:rs200587413)"
FT                   /evidence="ECO:0000269|PubMed:15253708"
FT                   /id="VAR_071228"
FT   VARIANT         211
FT                   /note="S -> A (in NPHS2)"
FT                   /evidence="ECO:0000269|PubMed:17899208"
FT                   /id="VAR_072149"
FT   VARIANT         213
FT                   /note="A -> T (in NPHS2)"
FT                   /evidence="ECO:0000269|PubMed:17899208"
FT                   /id="VAR_072150"
FT   VARIANT         218
FT                   /note="V -> G (in NPHS2)"
FT                   /evidence="ECO:0000269|PubMed:17899208"
FT                   /id="VAR_072151"
FT   VARIANT         221
FT                   /note="T -> I (in NPHS2)"
FT                   /evidence="ECO:0000269|PubMed:20947785"
FT                   /id="VAR_071229"
FT   VARIANT         228
FT                   /note="H -> D (in NPHS2)"
FT                   /evidence="ECO:0000269|PubMed:17899208"
FT                   /id="VAR_072152"
FT   VARIANT         229
FT                   /note="R -> L (in NPHS2)"
FT                   /evidence="ECO:0000269|PubMed:17899208"
FT                   /id="VAR_072153"
FT   VARIANT         229
FT                   /note="R -> Q (in NPHS2; uncertain significance;
FT                   dbSNP:rs61747728)"
FT                   /evidence="ECO:0000269|PubMed:12464671,
FT                   ECO:0000269|PubMed:20798252, ECO:0000269|PubMed:21722858,
FT                   ECO:0000269|PubMed:23800802, ECO:0000269|PubMed:24509478,
FT                   ECO:0000269|PubMed:26420286, ECO:0000269|PubMed:27004616"
FT                   /id="VAR_071230"
FT   VARIANT         236..238
FT                   /note="Missing (in NPHS2)"
FT                   /evidence="ECO:0000269|PubMed:15253708"
FT                   /id="VAR_071231"
FT   VARIANT         237
FT                   /note="E -> Q (in dbSNP:rs146906190)"
FT                   /evidence="ECO:0000269|PubMed:15253708,
FT                   ECO:0000269|PubMed:23595123, ECO:0000269|PubMed:24227627"
FT                   /id="VAR_071232"
FT   VARIANT         238
FT                   /note="R -> S (in NPHS2; dbSNP:rs748812981)"
FT                   /evidence="ECO:0000269|PubMed:15253708,
FT                   ECO:0000269|PubMed:24072147"
FT                   /id="VAR_071233"
FT   VARIANT         242
FT                   /note="A -> V (in dbSNP:rs61747727)"
FT                   /evidence="ECO:0000269|PubMed:15253708"
FT                   /id="VAR_071234"
FT   VARIANT         254
FT                   /note="C -> F (in NPHS2; uncertain significance)"
FT                   /evidence="ECO:0000269|PubMed:23595123"
FT                   /id="VAR_087599"
FT   VARIANT         260
FT                   /note="V -> E (in NPHS2; dbSNP:rs775006954)"
FT                   /evidence="ECO:0000269|PubMed:15253708,
FT                   ECO:0000269|PubMed:22565185, ECO:0000269|PubMed:23595123,
FT                   ECO:0000269|PubMed:26420286"
FT                   /id="VAR_071235"
FT   VARIANT         264
FT                   /note="E -> Q (in dbSNP:rs369697947)"
FT                   /evidence="ECO:0000269|PubMed:20947785,
FT                   ECO:0000269|PubMed:24227627"
FT                   /id="VAR_071236"
FT   VARIANT         267
FT                   /note="D -> N (in NPHS2)"
FT                   /evidence="ECO:0000269|PubMed:17899208"
FT                   /id="VAR_072154"
FT   VARIANT         268
FT                   /note="V -> L (in NPHS2)"
FT                   /evidence="ECO:0000269|PubMed:17899208"
FT                   /id="VAR_072155"
FT   VARIANT         276
FT                   /note="H -> L (in NPHS2)"
FT                   /evidence="ECO:0000269|PubMed:17899208"
FT                   /id="VAR_072156"
FT   VARIANT         281
FT                   /note="E -> A (in NPHS2)"
FT                   /evidence="ECO:0000269|PubMed:20947785"
FT                   /id="VAR_071237"
FT   VARIANT         281
FT                   /note="E -> K (in NPHS2)"
FT                   /evidence="ECO:0000269|PubMed:24227627"
FT                   /id="VAR_071238"
FT   VARIANT         284
FT                   /note="A -> V (in NPHS2; uncertain significance;
FT                   dbSNP:rs780761368)"
FT                   /evidence="ECO:0000269|PubMed:26420286"
FT                   /id="VAR_075617"
FT   VARIANT         290
FT                   /note="V -> M (in NPHS2; dbSNP:rs200482683)"
FT                   /evidence="ECO:0000269|PubMed:20798252,
FT                   ECO:0000269|PubMed:22578956, ECO:0000269|PubMed:23242530"
FT                   /id="VAR_071239"
FT   VARIANT         291
FT                   /note="R -> W (in NPHS2; dbSNP:rs74315348)"
FT                   /evidence="ECO:0000269|PubMed:10742096,
FT                   ECO:0000269|PubMed:20798252"
FT                   /id="VAR_010236"
FT   VARIANT         296
FT                   /note="E -> K (in NPHS2)"
FT                   /evidence="ECO:0000269|PubMed:24227627"
FT                   /id="VAR_071240"
FT   VARIANT         297
FT                   /note="A -> V (in dbSNP:rs199506378)"
FT                   /evidence="ECO:0000269|PubMed:20798252"
FT                   /id="VAR_079809"
FT   VARIANT         301
FT                   /note="Missing (in NPHS2)"
FT                   /evidence="ECO:0000269|PubMed:17899208"
FT                   /id="VAR_072157"
FT   VARIANT         309
FT                   /note="A -> V (in NPHS2)"
FT                   /evidence="ECO:0000269|PubMed:24227627"
FT                   /id="VAR_071241"
FT   VARIANT         310
FT                   /note="E -> K (in NPHS2; uncertain significance;
FT                   dbSNP:rs1673254835)"
FT                   /evidence="ECO:0000269|PubMed:26420286"
FT                   /id="VAR_075618"
FT   VARIANT         310
FT                   /note="E -> V (in NPHS2; uncertain significance;
FT                   dbSNP:rs1572255744)"
FT                   /evidence="ECO:0000269|PubMed:20798252"
FT                   /id="VAR_079810"
FT   VARIANT         315
FT                   /note="T -> I (in NPHS2; uncertain significance)"
FT                   /evidence="ECO:0000269|PubMed:24227627"
FT                   /id="VAR_071242"
FT   VARIANT         322
FT                   /note="R -> Q (in NPHS2; dbSNP:rs776859868)"
FT                   /evidence="ECO:0000269|PubMed:17899208"
FT                   /id="VAR_072158"
FT   VARIANT         328
FT                   /note="Q -> R (in NPHS2; uncertain significance;
FT                   dbSNP:rs1673239865)"
FT                   /evidence="ECO:0000269|PubMed:20798252"
FT                   /id="VAR_079811"
FT   VARIANT         333
FT                   /note="E -> G (in NPHS2; uncertain significance;
FT                   dbSNP:rs866921812)"
FT                   /evidence="ECO:0000269|PubMed:24227627"
FT                   /id="VAR_071243"
FT   VARIANT         341
FT                   /note="P -> S (in NPHS2; dbSNP:rs1214047676)"
FT                   /evidence="ECO:0000269|PubMed:22565185"
FT                   /id="VAR_072159"
FT   VARIANT         370
FT                   /note="V -> G (in NPHS2)"
FT                   /evidence="ECO:0000269|PubMed:17899208"
FT                   /id="VAR_072160"
FT   CARBOHYD        Q9NP85-2:287
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:23648087"
SQ   SEQUENCE   383 AA;  42201 MW;  BBB57783C840F752 CRC64;
     MERRARSSSR ESRGRGGRTP HKENKRAKAE RSGGGRGRQE AGPEPSGSGR AGTPGEPRAP
     AATVVDVDEV RGSGEEGTEV VALLESERPE EGTKSSGLGA CEWLLVLISL LFIIMTFPFS
     IWFCVKVVQE YERVIIFRLG HLLPGRAKGP GLFFFLPCLD TYHKVDLRLQ TLEIPFHEIV
     TKDMFIMEID AICYYRMENA SLLLSSLAHV SKAVQFLVQT TMKRLLAHRS LTEILLERKS
     IAQDAKVALD SVTCIWGIKV ERIEIKDVRL PAGLQHSLAV EAEAQRQAKV RMIAAEAEKA
     ASESLRMAAE ILSGTPAAVQ LRYLHTLQSL STEKPSTVVL PLPFDLLNCL SSPSNRTQGS
     LPFPSPSKPV EPLNPKKKDS PML
//
